MGAM and thymoma: It is tempting to speculate that the reduced thymoma incidence and lower TitinAb/RyRAb positivity in TPOAb + TgAb- MG might be linked to an IFN-γ-dominant immune milieu, which could potentially suppress Th17 differentiation.